GTR Test Accession:
Help
GTR000592964.2
CAP
Last updated in GTR:
2023-03-13
View version history
GTR000592964.2,
last updated:
2023-03-13
GTR000592964.1,
registered in GTR:
2021-04-29
Last annual review date for the lab: 2024-04-04
LinkOut
At a Glance
Test purpose:
Help
Diagnosis
Conditions (3):
Help
CFHR5 deficiency;
Afibrinogenemia;
Factor H deficiency
Genes (6):
Help
Methods (2):
Help
Molecular Genetics - Deletion/duplication analysis: qPCR; ...
Target population: Help
Not provided
Clinical validity:
Help
This panel can be used for the diagnosis of C3 …
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Buccal swab
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Health Care Provider
- Licensed Physician
Test Order Code:
Help
P1214
How to Order:
Help
Test service:
Help
Custom Deletion/Duplication Testing
Custom Sequence Analysis
Result interpretation
Custom Sequence Analysis
Result interpretation
Test development:
Help
Test developed by laboratory (no manufacturer test name)
Informed consent required:
Help
Decline to answer
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Lab contact for this test,
Contact policy,
Test strategy
Conditions
Help
Total conditions: 3
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 6
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 2
Method Category
Help
Test method
Help
Instrument *
Deletion/duplication analysis
qPCR
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis
Clinical validity:
Help
This panel can be used for the diagnosis of C3 Glomerulopathy (C3G), a form of complement-mediated kidney disease that is characterized by uncontrolled activation of the complement cascade leading to C3 deposition within the glomerulus.
View citations (1)
- Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodríguez de Córdoba S, Roumenina LT, Sethi S, Smith RJ, . Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Kidney Int. 2017;91(3):539-551. doi:10.1016/j.kint.2016.10.005. Epub 2016 Dec 16. PMID: 27989322.
Recommended fields not provided:
Clinical utility,
Target population,
What is the protocol for interpreting a variation as a VUS?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
During validation, no false negatives or false positive results were observed. Analytical specificity and sensitivity are >99%.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Reviews:
Clinical resources:
Molecular resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.